Navigation Links
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
Date:11/12/2008

MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the third quarter ended September 30, 2008.

The net loss for the third quarter ended September 30, 2008 was $20.4 million compared with $9.8 million during the same period in 2007. The net loss for the nine months ended September 30, 2008 was $51.1 million compared to $25.2 million for the nine months ended September 30, 2007. As of September 30, 2008, MAP Pharmaceuticals had cash, cash equivalents and short-term investments of $63.0 million.

"We had a very busy and productive third quarter with two active Phase 3 clinical programs ongoing. We completed patient enrollment of our Phase 3 trial of Unit Dose Budesonide, or UDB, for the potential treatment of pediatric asthma, and continued enrollment of our Phase 3 trial of MAP0004 for the potential treatment of migraine," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "In this environment, we continue to manage our resources prudently as we advance toward our goal of commercializing clearly differentiated products that address major market opportunities."

Third Quarter 2008 and Recent Accomplishments

Clinical development

-- UDB: Completed enrollment and randomized approximately 360 patients in a Phase 3 clinical trial to evaluate UDB for the potential treatment of pediatric asthma. The last patient in this trial is expected to complete the 12-week treatment period by the end of 2008.

-- MAP0004: Initiated enrollment in a Phase 3 clinical trial to evaluate MAP0004 for the potential treatment of migraine, pursuant to a Special Protocol Assessment with the U.S. Food and Drug Admin
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
7. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
8. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
9. Alseres Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
11. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 Today ... Luis Obispo), in partnership with the California Healthcare ... Disorders (NORD), presented an Assembly resolution recognizing Feb. ... families and healthcare professionals caring for millions of ... is a nonprofit, public policy research organization, representing ...
(Date:3/2/2015)... 2015 Today the Brain Injury Association of ... time to recognize and support the more than 5.3 million ... year BIAA leads the nation in observing Brain Injury Awareness ... March. The theme for the 2015 to 2017 campaign is: ... platform for educating the general public about the incidence of ...
(Date:3/2/2015)... March 02, 2015 A cocaine ... deviating from the typical nip slip or scathing scuffle. ... industry is dawning the streets of Hollywood as Paper ... about drug addiction and substance abuse in Hollywood. The ... to take a political stance on the travails of ...
(Date:3/2/2015)... “ Wants and Needs ” was ... which features the latest and coolest mobile applications on ... mobile technology expert and host of NewsWatch, conducted the ... helps people evaluate priorities. , Whether a person needs ... Needs app. The app allows people to enter and ...
(Date:3/2/2015)... OR (PRWEB) March 02, 2015 ... plan to remake American healthcare. Zoom will expand ... 28 neighborhood clinics and advanced care studios delivering ... health, emergency services, specialty care and outpatient surgery. ... on-demand access to almost all healthcare needs outside ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 3Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) ... and linked to increased rates of potentially dangerous low ... drug was approved in 2001 to help heart failure ... severe shortness of breath. But the drug had no ...
... expanded access to health care facilitated by health care reform ... and other advanced medical professionals. According to a study published ... American College of Surgeons, the United States will face ... nurses, and physician assistants over the next two decades. The ...
... WEDNESDAY, July 6 (HealthDay News) -- Simpler and shorter ... in millions of people worldwide infected with the bacterium ... researchers report. TB, or tuberculosis, is the leading ... virus that causes AIDS. About half a million people ...
... , WEDNESDAY, July 6 (HealthDay News) -- Move over, Lyme ... parts of the country, and this one can kill. ... parasite that attacks blood cells, causing flu-like symptoms that can ... is caused by bacteria, babesia microti parasites are carried by ...
... in The Journal of Sexual Medicine reveals ... physical inactivity, high alcohol consumption, tobacco smoking, and hard ... an unhealthy lifestyle is more common in persons who ... Frisch, MD, PhD, DSc, of Statens Serum Institut, used ...
... Ga. Altering the body,s metabolism could be an ... The finding that inhibiting heat shock transcription factor 1, ... another wake-up call that a low-fat, healthy diet is ... Virologist/Immunologist at Georgia Health Sciences University. HSF1 and its ...
Cached Medicine News:Health News:Study Finds Heart Failure Drug Ineffective 2Health News:Study Finds Heart Failure Drug Ineffective 3Health News:Study Finds Heart Failure Drug Ineffective 4Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News:New Combo Therapy May Prevent TB, Save Lives in People With HIV 2Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3Health News:An unhealthy lifestyle is associated with sexual dysfunction 2Health News:Transcription factor is potential target for liver cancer treatment 2
(Date:3/2/2015)... For the past 15 years, there has been an ... U.S. alone (U.S. Census Bureau 2012). Of course, not every accident ... there are quite a few where the car occupants can get ... the seatbelt release button or occupant injury. One ... in their lifetime but may still be "lucky" enough to come ...
(Date:3/2/2015)... Following announcements from both Novartis and ... Inc. (NASDAQ:  ARRY) today announced the completion of ... Novartis.  Along with global ownership of both assets, ... million from Novartis. Ron Squarer, Chief ... the Novartis-GSK transaction, Array now owns both binimetinib ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 ... HealthCare are kicking off the 2015 One ... The month-long national campaign will raise awareness and funds ... the more than one million colorectal cancer survivors living ... fight this disease with great strength and courage every ...
Breaking Medicine Technology:New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5
... Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ), ... today that the company is partnering with The ... Houston, Texas to launch a prospective,clinical study to ... in the study will be randomly assigned to ...
... announces data presented at AACR-NCI-EORTC ... ... (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned ... candidates during the 19th annual AACR-NCI-EORTC Symposium. "These studies show ...
Cached Medicine Technology:M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
Medicine Products: